Aarti Drugs reports 10 pct loss at Rs 21 cr in Q3 FY19

Drug firm Aarti Drugs Monday reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore for the quarter ended December 31, 2018. The company had posted a net profit of Rs 23.33 crore for the corresponding period of the previous fiscal, Aarti Drugs said in a filing to BSE.

Consolidated revenue from operations of the company, however, stood at Rs 380.11 crore for the quarter under consideration as against Rs 335.41 crore for October-December 2017. Shares of Aarti Drugs closed at Rs 592.70 on BSE, up 1.50 per cent from the previous close.